Electroencephalography (EEG) Devices Market Size Worth $2.92 Billion By 2032 | CAGR: 3.4%

Electroencephalography (EEG) Devices Market Size Worth $2.92 Billion By 2032 | CAGR: 3.4%


The global electroencephalography (EEG) devices market size is expected to reach USD 2.92 billion by 2032, according to a new study by Polaris Market Research. The report “Electroencephalography (EEG) Devices Market Share, Size, Trends, Industry Analysis Report, By Modality (Portable, Standalone); By Product; By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Electroencephalography (EEG) devices are medical devices used to measure and record the brain's electrical activity. EEG is a non-invasive technique that involves placing electrodes on the scalp to detect and record the electrical signals generated by the brain's neurons.

The EEG devices consist of electrodes connected to an amplifier or a computer system. These electrodes pick up the electrical signals produced by the brain and convert them into waveforms that healthcare professionals can analyze and interpret.

EEG is commonly used in clinical settings to diagnose and monitor neurological conditions like epilepsy, sleep disorders, brain tumors, and brain injuries. It helps healthcare professionals to evaluate brain function, detect abnormalities, and assess the effectiveness of treatments.

In addition to clinical applications, EEG devices are utilized in research settings to study brain activity, cognitive processes, and the effects of certain stimuli or interventions on the brain.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/electroencephalography-eeg-devices-market/request-for-sample

Several key factors drive the growth of the electroencephalography (EEG) equipment market. The increasing elderly population and the growing adoption of EEG equipment in surgical centers are major contributors—additionally, the rising prevalence of neurological disorders like epilepsy and Alzheimer's disease further fuels market growth.

Technological advancements in EEG equipment also play a significant role in driving market growth. However, the presence of substitute products poses a challenge to market expansion. On the other hand, there is substantial growth potential in developing nations, presenting lucrative opportunities for the global EEG equipment market in the forecast period.

The growth of the electroencephalography (EEG) devices market is driven by the rising prevalence of neurological conditions and growing awareness about them. Neurological disorders such as epilepsy, Alzheimer's, multiple sclerosis, dementia, stroke, and Parkinson's disease have increased demand for EEG devices. For example, In 2022, according to the Association for Alzheimer's Disease, approximately 6.5 million Americans aged 65 and older will be affected by Alzheimer's, with 73% being 75 years or older. This data highlights the significant impact of neurological disorders on adopting EEG devices.

Electroencephalography (EEG) Devices Market Report Highlights

  • During the forecast period in the Electroencephalography (EEG) Devices Market, the 32-channel EEG segment held the largest revenue share. It indicates that EEG devices with 32 channels, which enable the simultaneous recording of electrical brain activity from multiple locations, were in high demand.
  • In 2022, the hospital segment held the highest Electroencephalography (EEG) Devices Market share. It signifies that hospitals were the primary users and purchasers of EEG devices during that period.
  • In 2022, North America dominanted region in the global Electroencephalography (EEG) Devices Market. It indicates its strong presence and position in the EEG devices market. The region's emphasis on technological advancements and a favorable reimbursement scenario further contributed to its market administration in EEG devices.
  • The global key market players include Cephalon A/S, BrainScope Company Inc., Nihon Kohden America, Electrical Geodesics, Inc., Compumedics Ltd., Natus Medical, Inc., Elekta AB, Koninklijke Philips, NeuroScience Inc., Lifelines Neurodiagnostic Devices Inc., Bio-Signal Group Corp., Medtronic, Neurosoft Ltd., Cadwell Laboratories, Inc., Inc., and NeuroWave Devices, Inc.

Polaris Market Research has segmented the electroencephalography (EEG) devices market report based on modality, product, application, end-use, and region:

Electroencephalography (EEG) Devices, Modality Outlook (Revenue - USD Billion, 2019 - 2032)

  • Portable
  • Standalone

Electroencephalography (EEG) Devices, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • 8-channel EEG
  • 21-channel EEG
  • 25-channel EEG
  • 32-channel EEG
  • 40-channel EEG
  • Multichannel EEG
  • Others

Electroencephalography (EEG) Devices, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Trauma & Surgery
  • Disease Diagnosis
  • Anesthesia Monitoring
  • Sleep Monitoring
  • Others

Electroencephalography (EEG) Devices, End-Use (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Laboratories
  • Others

Electroencephalography (EEG) Devices, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Electroencephalography (EEG) Devices Market Report Scope

Report Attributes

Details

Market size value in 2023

USD 2.16 billion

Revenue forecast in 2032

USD 2.92 billion

CAGR

3.4% from 2023 – 2032

Base year

2022

Historical data

2019 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2023 to 2032

Segments Covered

By Modality, By Product, By Application, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key Companies

Cephalon A/S, BrainScope Company Inc., Electrical Geodesics, Inc., Compumedics Ltd., Elekta AB, Koninklijke Philips, NeuroScience Inc., Lifelines Neurodiagnostic Devices Inc., Bio-Signal Group Corp., Natus Medical, Inc., Medtronic, Neurosoft Ltd., Cadwell Laboratories, Inc., Nihon Kohden America, Inc., and NeuroWave Devices, Inc.

For Specific Research Requirements

Request for Customized Report